http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010540606-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
filingDate 2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2010540606-A
titleOfInvention Therapeutic use of diaminophenothiazine
abstract The present invention relates generally to methods and materials for use in the treatment or prevention of diseases (eg, cognitive impairment) using diaminophenothiazine. In particular, the present invention relates to treatments with optimized pharmacokinetic properties, and the dosage form is intended to improve the relative cognition of this diaminophenothiazine or CNS benefits, eg, compared to hematological effects. Has been. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019526571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019527216-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7073330-B2
priorityDate 2007-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009531403-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009542786-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004524831-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415860082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19825832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467935496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4371797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467935494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466641546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430948655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426030646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154042482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422732168

Total number of triples: 38.